Guner Kilic, Gulce Ecem Kilic, Adnan Ozkahraman, Yusuf Kayar
{"title":"Correlation of hyperglycemia and balthazar classification in patients with acute pancreatitis.","authors":"Guner Kilic, Gulce Ecem Kilic, Adnan Ozkahraman, Yusuf Kayar","doi":"10.12669/pjms.40.10.6687","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>High levels of glucose during acute pancreatitis (AP) progression influence disease progression by promoting the release of inflammatory cytokines. The aim of this study was to evaluate the effects of both the blood glucose level in patients without diabetes mellitus (DM) and the presence of DM on the severity and course of AP in patients presenting with clinical AP.</p><p><strong>Methods: </strong>The study included 343 patients who were hospitalized at Van Training and Research Hospital, Turkey and followed up with the diagnosis of AP between 2014 and 2018. The patients were separated into two groups as diabetic and non-diabetic. The relationship between DM and the severity and course of AP was examined in the two groups.</p><p><strong>Results: </strong>The DM group included 52 (15.1%) patients, and the non- DM group included 291 (84.9%) patients. In the non-DM group, the serum glucose level was <125 mg/dl in 160 (54.9 %) patients, and >125 mg/dl in 131 (45.1 %) patients. In the comparison of AP severity in the diabetic and non-diabetic groups, the rate of severe AP was determined to be significantly higher in the diabetic group according to the Modified Balthazar classification, evaluated from tomographies taken on admission and on the 3rd day (p:0.026, p:0.001, respectively).</p><p><strong>Conclusion: </strong>Elevated blood glucose is relatively common in patients with AP and has a negative impact on the disease process. A high glucose level can increase the severity of AP and slow healing.</p>","PeriodicalId":19958,"journal":{"name":"Pakistan Journal of Medical Sciences","volume":"40 10","pages":"2271-2276"},"PeriodicalIF":1.2000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11568707/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pakistan Journal of Medical Sciences","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.12669/pjms.40.10.6687","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: High levels of glucose during acute pancreatitis (AP) progression influence disease progression by promoting the release of inflammatory cytokines. The aim of this study was to evaluate the effects of both the blood glucose level in patients without diabetes mellitus (DM) and the presence of DM on the severity and course of AP in patients presenting with clinical AP.
Methods: The study included 343 patients who were hospitalized at Van Training and Research Hospital, Turkey and followed up with the diagnosis of AP between 2014 and 2018. The patients were separated into two groups as diabetic and non-diabetic. The relationship between DM and the severity and course of AP was examined in the two groups.
Results: The DM group included 52 (15.1%) patients, and the non- DM group included 291 (84.9%) patients. In the non-DM group, the serum glucose level was <125 mg/dl in 160 (54.9 %) patients, and >125 mg/dl in 131 (45.1 %) patients. In the comparison of AP severity in the diabetic and non-diabetic groups, the rate of severe AP was determined to be significantly higher in the diabetic group according to the Modified Balthazar classification, evaluated from tomographies taken on admission and on the 3rd day (p:0.026, p:0.001, respectively).
Conclusion: Elevated blood glucose is relatively common in patients with AP and has a negative impact on the disease process. A high glucose level can increase the severity of AP and slow healing.
目的:急性胰腺炎(AP)进展期间的高血糖水平会促进炎症细胞因子的释放,从而影响疾病的进展。本研究旨在评估无糖尿病(DM)患者的血糖水平和有糖尿病(DM)患者的血糖水平对临床胰腺炎患者胰腺炎严重程度和病程的影响:研究纳入了2014年至2018年期间在土耳其范培训与研究医院住院并随访确诊为AP的343名患者。患者分为糖尿病和非糖尿病两组。研究了两组患者中糖尿病与 AP 的严重程度和病程之间的关系:DM组包括52名(15.1%)患者,非DM组包括291名(84.9%)患者。在非糖尿病组中,131 名患者(45.1%)的血清葡萄糖水平为 125 mg/dl。在比较糖尿病组和非糖尿病组的 AP 严重程度时,根据入院时和第 3 天的断层扫描结果,按照改良巴尔塔扎尔分类法,糖尿病组的严重 AP 率明显更高(分别为 p:0.026 和 p:0.001):血糖升高在 AP 患者中较为常见,对疾病进程有负面影响。结论:血糖升高在 AP 患者中较为常见,会对疾病进程产生负面影响,高血糖会加重 AP 的严重程度并延缓愈合。
期刊介绍:
It is a peer reviewed medical journal published regularly since 1984. It was previously known as quarterly "SPECIALIST" till December 31st 1999. It publishes original research articles, review articles, current practices, short communications & case reports. It attracts manuscripts not only from within Pakistan but also from over fifty countries from abroad.
Copies of PJMS are sent to all the import medical libraries all over Pakistan and overseas particularly in South East Asia and Asia Pacific besides WHO EMRO Region countries. Eminent members of the medical profession at home and abroad regularly contribute their write-ups, manuscripts in our publications. We pursue an independent editorial policy, which allows an opportunity to the healthcare professionals to express their views without any fear or favour. That is why many opinion makers among the medical and pharmaceutical profession use this publication to communicate their viewpoint.